Primary Cicatricial Alopecias

    October 2012 in “ Dermatologic Clinics ”
    Nina Otberg
    Image of study
    TLDR Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.
    The document from 2013 provides an overview of Primary Cicatricial Alopecias (PCAs), a group of rare inflammatory scalp disorders that lead to permanent hair loss due to the destruction of hair follicle stem cells. It emphasizes the importance of early diagnosis and aggressive treatment to manage these conditions. The document classifies PCAs into lymphocytic, neutrophilic, and mixed groups based on the predominant inflammatory cells involved and details the clinical presentation, pathology, risk factors, and management of various PCAs, including Chronic Cutaneous Lupus Erythematosus (DLE), Lichen Planopilaris (LPP), Pseudopelade of Brocq (PPB), Central Centrifugal Cicatricial Alopecia (CCCA), Alopecia Mucinosa (AM), Keratosis Follicularis Spinulosa Decalvans (KFSD), Folliculitis Decalvans (FD), Dissecting Folliculitis (DF), and Acne Keloidalis. It outlines treatment options such as hydroxychloroquine, corticosteroids, immunosuppressive therapies, antimalarials, antistaphylococcal antibiotics, isotretinoin, and surgical interventions, with the goal of halting disease progression and addressing cosmetic concerns. Images provided by Dr. Jerry Shapiro from the UBC Hair Clinic in Vancouver, British Columbia, Canada, support the document.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    6 / 289 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  119 upvotes 6 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    8 / 8 results